Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method

International Journal of Antimicrobial Agents

Volumn 31, Issue 5, 2008, Pages 458-462

  Viveiros, Miguel ^a   Martins, Ana ^a   Paixão, Laura ^a   Rodrigues, Liliana ^a   Martins, Marta ^a   Couto, Isabel ^a,b   Fähnrich, Eva ^c   Kern, Winfried V ^c   Amaral, Leonard ^a  

^a INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Automated method; Bacterial efflux pumps; Efflux pump inhibitors; Escherichia coli; Ethidium bromide; Fluorometry

Indexed keywords

ETHIDIUM BROMIDE; GLUCOSE;

ARTICLE; DRUG ACCUMULATION; ENERGY; ESCHERICHIA COLI K 12; FLUOROMETRY; GENE; INSTRUMENT; LOW TEMPERATURE; MICROBIAL ACTIVITY; NONHUMAN; PRIORITY JOURNAL; SCREENING;

BIOLOGICAL TRANSPORT; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI K12; ETHIDIUM; MICROBIOLOGICAL TECHNIQUES;

EID: 41949109742     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.12.015     Document Type: Article

References (15)

1. Amaral L., Engi H., Viveiros M., and Molnar J. Comparison of multidrug resistant efflux pumps of cancer and bacterial cells with respect to the same inhibitory agents. In Vivo 21 (2007) 237-244
2. Martins M., Santos B., Martins A., Viveiros M., Couto I., Cruz A., et al. An instrument-free method for the demonstration of efflux pump activity of bacteria. In Vivo 20 (2006) 657-664
3. Schumacher A., Trittler R., Bohnert J.A., Kummerer K., Pagès J.M., and Kern W.V. Intracellular accumulation of linezolid in Escherichia coli, Citrobacter freundii and Enterobacter aerogenes: role of enhanced efflux pump activity and inactivation. J Antimicrob Chemother 59 (2006) 1261-1264
4. Lomovskaya O., Zgurskaya H.I., Totrov M., and Watkins W.J. Waltzing transporters and 'the dance macabre' between humans and bacteria. Nat Rev Drug Discov 6 (2007) 56-65
5. Piddock L.J. Multidrug-resistance efflux pumps-not just for resistance. Nat Rev Microbiol 4 (2006) 629-636
6. Zgurskaya I.H., and Nikaido H. Bypassing the periplasm: reconstitution of the AcrAB multidrug efflux pump of Escherichia coli. Proc Natl Acad Sci USA 96 (1999) 7190-7195
7. Okusu H., Ma D., and Nikaido H. AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. J Bacteriol 178 (1996) 306-308
8. Viveiros M., Jesus A., Brito M., Leandro C., Martins M., Ordway D., et al. Inducement and reversal of tetracycline resistance in Escherichia coli K-12 and expression of proton gradient-dependent multidrug efflux pump genes. Antimicrob Agents Chemother 49 (2005) 3578-3582
9. Viveiros M., Dupont M., Rodrigues L., Couto I., Davin-Regli A., Martins M., et al. Antibiotic stress, genetic response and altered permeability of E. coli. PLoS ONE 2 (2007) e365
10. Eliopoulos G.M., and Moellering R.C. Antimicrobial combinations. In: Lorian V. (Ed). Antibiotics in laboratory medicine (1991), Williams and Wilkins Co., Baltimore, MD
11. Elkins C.A., and Nikaido H. 3D structure of AcrB: the archetypal multidrug efflux transporter of Escherichia coli likely captures substrates from periplasm. Drug Resist Updat 6 (2003) 9-13
12. Jernaes M.W., and Steen H.B. Staining of Escherichia coli for flow cytometry: influx and efflux of ethidium bromide. Cytometry 17 (1994) 302-309
13. Amaral L., Martins M., and Viveiros M. Phenothiazines as anti-multi-drug resistant tubercular agents. Infect Disord Drug Targets 7 (2007) 257-265
14. Kern W., Steinke P., Schumacher A., Schuster S., von Baum H., and Bohnert J.A. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli. J Antimicrob Chemother 57 (2006) 339-343
15. Schumacher A., Steinke P., Bohnert J.A., Akova M., Jonas D., and Kern W.V. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli. J Antimicrob Chemother 57 (2006) 344-348